NanoString Technologies Inc.

199 articles with NanoString Technologies Inc.

• NanoString Technologies Inc. to Raise $54 Million in IPO

  6/26/2013

• Results of New Analysis Support Use of NanoString Technologies Inc.’s Prosigna™ Assay to Help Identify Node-Positive Early-Stage Breast Cancer Patients at Low Risk of Recurrence

  6/3/2013

• NanoString Technologies Inc. Announces Oral Study Presentation of the Prosigna™ Assay in Postmenopausal Node-Positive Breast Cancer at the 2013 Annual American Society of Clinical Oncology

  6/3/2013

• NanoString Technologies Inc. Maneuvers in Line for $86 Million IPO

  5/21/2013

• NanoString Technologies Inc. Announces Oral Study Presentation of the Prosigna™ Assay in Postmenopausal Node-Positive Breast Cancer at the 2013 Annual American Society of Clinical Oncology

  5/16/2013

• NanoString Technologies Inc. Secures Option From the Broad Institute for Exclusive Worldwide License of Liver Cancer Gene Signature

  4/17/2013

• NanoString Technologies Inc. Presents Positive Results From Multisite Analytical Validation Study of Prosigna™ Breast Cancer

  3/6/2013

• NanoString Technologies Inc. Expands Leadership Team With the Hiring of Two Seasoned Executives

  2/28/2013

• NanoString Technologies Inc. Launches Its First Commercial Diagnostic Product in the European Union and Israel

  2/19/2013

• NanoString Technologies Inc. Announces Positive Results From Second Validation Study of PAM50-based Breast Cancer Assay

  12/6/2012

• NanoString Technologies Inc. Completes $15.3 Million Series E Financing

  12/3/2012

• Fluidigm Corporation Files Lawsuit Against NanoString Technologies Inc.'s Deceptive Marketing

  11/8/2012

• NanoString Technologies Inc. Appoints James A. Johnson as Chief Financial Officer

  10/3/2012

• NanoString Technologies Inc. Obtains CE Mark for PAM50-Based Test for Breast Cancer

  9/27/2012

• NanoString Technologies Inc. Release: The Cancer Genome Atlas (TCGA) Study Supports Power of Subtyping Breast Cancer by PAM50

  9/25/2012

• NanoString Technologies Inc. Launches Single Cell Gene Expression Solution for Its nCounter® Analysis System

  9/25/2012

• NanoString Technologies Inc. Names Dale R. Levitzke Vice President of Global Sales for Life Sciences

  8/7/2012

• NanoString Technologies Inc. Names Bruce Seeley Senior Vice President & General Manager, Diagnostics

  5/29/2012

• NanoString Technologies Inc. Initiates Second Clinical Validation Study for Breast Cancer Assay

  5/16/2012

• NanoString Technologies Inc. Names Joseph M. Beechem Senior Vice President of R&D

  4/9/2012